Self-reported adverse effects as barriers to adherence to antiretroviral therapy in HIV-infected patients in Pretoria

South African Family Practice

Volumn 50, Issue 5, 2008, Pages

  Malangu, N Gustav ^a  

^a UNIVERSITY OF LIMPOPO   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ANOREXIA; ARTHRALGIA; ARTICLE; DEPRESSION; DIARRHEA; DIZZINESS; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FEVER; HAIR LOSS; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; LIBIDO DISORDER; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MYALGIA; NIGHTMARE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PRESCRIPTION; RASH; SELF REPORT; SEXUAL DYSFUNCTION; SIDE EFFECT; SOUTH AFRICA; SUICIDAL IDEATION; THORAX PAIN; VOMITING;

EID: 60249092050     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: 10.1080/20786204.2008.10873763     Document Type: Article

References (16)

1. Roca B, Lapuebla C, Vidal-Tegedor B. HAART with didanosine once versus twice daily: adherence and efficacy. Int J Inf Dis 2005;9:195-200.
2. Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Aids 2001;15:1181-3.
3. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002;17:756-65.
4. Barroso PF, Schechter M, Gupta P, et al. Adherence to antiretroviral therapy and persistence of HIV RNA in semen. J Acquir Immune Defic Syndr 2003;32:435-40.
5. Pinheiro CA, De-Carvalho-Leite JC, Drachler ML, Silveira VL. Factors associated with adherence to antiretroviral therapy in HIV/AIDS patients: A cross-sectional study in Southern Brazil. Braz J Med Biol Res 2002;35:1173-81.
6. Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: Results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther 2002;7:185-93.
7. Bekker L, Orrell C, Reader R, et al. Antiretroviral therapy in a community clinic - early lessons from a pilot project. SA Med J 2003;93(6):458-62.
8. Malangu N. Self-reported use of traditional, complementary and over-the-counter medicines by HIV-infected patients on antiretroviral therapy in Pretoria, South Africa. Afr J Trad CAM 2007;4 (3):273-8.
9. Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. Aids 2003;17:1369-75.
10. Ncayiyana DJ. The looming threat of HIV/AIDS drug resistance in South Africa. S Afr Med J Aug 2004;94(8):1.
11. Cheung PK, Wynhoven B, Harrigan PR. Which HIV-1 Drug resistance mutations are common in clinical practice. AIDS Reviews 2004;6:107-16.
12. Scott VE, Chopra M, Conrad L, Ntuli A. How equitable is the scaling up of HIV service provision in South Africa? SA Med J Feb 2005;95(2):109-13.
13. Venter WD. A critical evaluation of the South African state antiretroviral programme. Southern Afr J HIV Med 2005;20:21-25, 28.
14. Hsiao AF, Wong MD, Kanouse DE, et al. Complementary and alternative medicine use and substitution for conventional therapy by HIV-infected patients. J Acquir Immune Defic Syndr 2003; 33:157-65.
15. Johnson MO, Charlebois E, Morin SF, et al. Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage. 2005 Feb;29(2):193-205.
16. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multi-center, cross-sectional study. AIDS and Behavior 2004;8(2):141-50.